Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.
about
Inhibition of Immune Checkpoints and Vascular Endothelial Growth Factor as Combination Therapy for Metastatic Melanoma: An Overview of Rationale, Preclinical Evidence, and Initial Clinical DataVascular normalization and cancer immunotherapyControl of the immune response by pro-angiogenic factorsAttenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesisCytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer.Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.Angiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1.Context- and cell-dependent effects of Delta-like 4 targeting in the bone marrow microenvironment.Chronic psychological stress induces the accumulation of myeloid-derived suppressor cells in mice.VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors.Resuscitating cancer immunosurveillance: selective stimulation of DLL1-Notch signaling in T cells rescues T-cell function and inhibits tumor growth.Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytesPlumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2CD4+VEGFR1(HIGH) T cell as a novel Treg subset regulates inflammatory bowel disease in lymphopenic miceAssociation of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma.Multivalent Forms of the Notch Ligand DLL-1 Enhance Antitumor T-cell Immunity in Lung Cancer and Improve Efficacy of EGFR-Targeted Therapy.Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapyTumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer.Understanding lymphangiogenesis in knockout models, the cornea, and ocular diseases for the development of therapeutic interventions.Host A(2B) adenosine receptors promote carcinoma growthVascular normalization as an emerging strategy to enhance cancer immunotherapy.VEGF-mediated cross-talk within the neonatal murine thymus.VEGF and pleiotrophin modulate the immune profile of breast cancer.Immunological off-target effects of standard treatments in gastrointestinal cancersCancer-associated myeloproliferation: old association, new therapeutic target.Small-molecule protein kinase inhibitors and their effects on the immune system: implications for cancer treatment.Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion.Myeloid-derived suppressor cells in transplantation and cancerNegative regulation of myeloid-derived suppressor cells in cancer.Modulation of immunity by antiangiogenic molecules in cancer.Review of angiogenesis in hepatocellular carcinoma.Myeloid-derived suppressor cells in B cell malignancies.Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma.Plumbagin and Its Role in Chronic Diseases.Barriers to Radiation-Induced In Situ Tumor Vaccination.From top to bottom: midkine and pleiotrophin as emerging players in immune regulation.Myeloid-derived suppressor cell and macrophage exert distinct angiogenic and immunosuppressive effects in breast cancer.The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells.
P2860
Q26781098-F7CA4C88-30D9-44E1-B03A-54EB3CB9CFDAQ26827437-DB6731F0-D4FB-4D31-859C-2251A31E50B5Q27004733-638CB1B8-2B9D-4B5A-8D95-EF9EEBFC2288Q28386225-C4236D8C-2C82-493D-8775-BC4FF2FE0A6FQ33514852-8BAC4FBC-37B6-4B4D-A65C-E7E07A83FA44Q33764990-FD937F80-686B-495A-928A-99A491EAE96BQ33847973-EFD04AF8-3215-454D-9CB1-2B72681C684CQ33873408-C8D69EE4-4B5B-4EB1-A696-3314454FB669Q34533929-74E697C4-92E4-42CA-985E-8CB54C1A7C18Q34994724-04CA2D97-A28D-4493-B8EA-F5D9D91F615CQ35064894-FDABCA17-ABDA-48BF-B344-C59F3EEE26FAQ35256189-D1E86BBA-ACD1-4593-990F-99B50DF7A341Q35798966-48647E55-B435-45A2-B5DB-D6C858DF1A7BQ35847903-911985D3-BCEB-442E-A0FF-F24CC6118F4AQ35940368-3E6EEF1A-165D-4816-9CD3-C29E4308A5D3Q36085110-962D092D-7921-4B5E-A8F4-F98D66EFC52BQ36275134-0FE3FC00-4E0C-4BE5-A319-AE4B985281B1Q36296504-F8F73BEF-3AE6-4694-A3BC-2FE0C4162018Q36378276-C61C7B89-09D9-41ED-AF2E-5519BA37EABEQ36617328-B7BE58C9-A4B6-4949-9C72-C68CABBEF88FQ36808641-4744D74C-2E8A-40C8-B350-A8B58909C340Q36840284-DAB8963F-0933-4C08-A5E3-17C1FF23450AQ36847357-64B13F51-9845-49A8-870D-864405F6C2EAQ37142168-4B2D3CB3-DCEC-45B9-8696-9532F53554D9Q37328378-D74C9BA3-E0B4-4925-A06A-FFE22977B423Q37404086-15576617-41F0-4761-A84B-7B6DEA27CD76Q37769017-C2D864CC-B2BD-41ED-A421-B1B2F79611C1Q37842326-AEE93F70-0142-49E9-A796-3329252498ADQ37856017-ECCF410D-FE39-4D41-AF6C-8230229380C3Q38005601-DDA15816-F739-4B4D-BE53-8E2C3521847CQ38047048-8CB80DF3-D794-49FD-9FF8-D5EC2A203622Q38074154-721F9808-70E1-41BA-954C-7DCE65A88B7FQ38188582-B516CBDD-2172-43DC-8940-7D2194049D42Q38578686-355D40A0-F52E-407D-9292-F4B293FBB479Q38728953-A9D3EC45-05C8-44B4-AD32-7CE73563971FQ38988584-49AC5D17-6D26-4422-AC0A-B69A7F237CF6Q39203685-0512F757-E957-4979-85C9-BA74B9C01E93Q39207404-4CE6A56C-1824-4C77-8F50-8D1543D50708Q41552935-B2C8AEDB-5F1E-46B7-A484-A0F4810D35FDQ41761209-BA0CA527-3A44-49B0-B464-3AA950C2B028
P2860
Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.
@ast
Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.
@en
type
label
Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.
@ast
Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.
@en
prefLabel
Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.
@ast
Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.
@en
P2093
P2860
P1433
P1476
Distinct roles of VEGFR-1 and ...... with elevated levels of VEGF.
@en
P2093
Claudio A Mosse
David P Carbone
Mikhail M Dikov
Sergey V Novitskiy
Xiaolan Chen
Yuhui Huang
P2860
P304
P356
10.1182/BLOOD-2007-01-065714
P407
P577
2007-03-21T00:00:00Z